Developing teeth show dose-dependent damage after pediatric head and neck rhabdomyosarcoma radiotherapy

In 34 survivors, 79% had dental abnormalities, with a modeled 50% probability of developmental damage at approximately 23 Gy EQD2.

KEY POINTS

  • This international multicenter cross-sectional study evaluated 34 survivors of pediatric head and neck rhabdomyosarcoma treated at four specialist centers. Median age at diagnosis was 5.6 years, median follow-up was 13.2 years, and local treatment included photon RT (n=10), proton therapy (n=9), or surgery with brachytherapy using the AMORE approach (n=15).
  • Late dental abnormalities were assessed using the validated DENTALE radiographic scoring system. Among 919 assessable permanent teeth, 242 (26.3%) showed at least one developmental abnormality, while 27 of 34 survivors (79.4%) had dental late effects. Evaluated abnormalities included crown morphology, root development, crown-to-root ratio, and eruption disturbances.
  • Radiation doses to deciduous dentition and tooth-bearing bone were reconstructed from original treatment plans and converted to EQD2 using α/β = 3 Gy, with proton RBE set to 1.1. Tooth-level logistic regression accounted for clustering of multiple teeth within individual survivors, allowing evaluation of dose–response relationships across treatment modalities.
  • The estimated dose corresponding to a 50% probability of any dental developmental abnormality was 22.9 Gy(EQD2) (p<0.001; AUC 0.700). This estimate was based on mean dose to the deciduous teeth and should be understood as a modeled TD50 within a chemotherapy-exposed survivor population, not as a validated clinical dose limit.
  • Structure-specific models identified relatively low TD50 estimates for root abnormalities at 23.8 Gy(EQD2) (AUC 0.703) and crown-to-root ratio disturbances at 36.9 Gy(EQD2) (AUC 0.777). These endpoints were modeled against mean dose to tooth-bearing bone, suggesting that root development may be particularly sensitive to radiation exposure during childhood.
  • Higher TD50 estimates were observed for crown developmental abnormalities at 67.6 Gy(EQD2) (AUC 0.728) and eruption disturbances at 51.8 Gy(EQD2) (AUC 0.790). However, the eruption model was affected by low event numbers and developmental heterogeneity, and the authors explicitly caution against interpreting its threshold as a clinical planning constraint.
  • Dental abnormalities were observed even in teeth receiving 0 Gy, consistent with a potential contribution from chemotherapy. The study could not reliably estimate a 5% toxicity dose threshold, distinguish radiation from chemotherapy effects, or compare treatment modalities; the proposed thresholds therefore require prospective validation before adoption as formal OAR constraints.

CLINICAL TAKEAWAY

Developing dentition should be considered an organ at risk during pediatric head and neck radiotherapy, particularly when treatment occurs during active tooth development. The estimated TD50 of approximately 23 Gy(EQD2) for dental abnormalities supports minimizing unnecessary dental exposure, but these exploratory dose–response thresholds are not validated safe-dose limits and reflect combined radiation and chemotherapy effects.

SOURCE

Radiotherapy and Oncology

Browse more research Suggest a correction